Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ramipril 5 mg + Hydrochlorothiazide 12.5 mg tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ramipil H Tablet is a fixed-dose combination of Ramipril (5 mg), an ACE inhibitor, and Hydrochlorothiazide (12.5 mg), a thiazide diuretic. This combination is effective in the management of essential hypertension by reducing blood volume and relaxing blood vessels. Ramipril lowers blood pressure by inhibiting the renin-angiotensin system, while Hydrochlorothiazide enhances the removal of excess salt and water, further aiding in blood pressure control and preventing cardiovascular events.
Commonly reported side effects include dizziness, headache, fatigue, dry cough, and increased urination. Some patients may experience electrolyte imbalances, low blood pressure, or gastrointestinal discomfort. Rarely, allergic reactions or kidney function disturbances may occur.
Ramipil H Tablet is indicated for the treatment of essential hypertension, especially in patients whose blood pressure is not adequately controlled by monotherapy. It is also used to lower the risk of stroke, heart attack, and other cardiovascular complications in hypertensive individuals.
To be used only under the supervision of a qualified healthcare provider. Avoid during pregnancy and in patients with known hypersensitivity to ACE inhibitors or thiazides. Regular monitoring of blood pressure, kidney function, and electrolyte levels is advised. Do not discontinue medication without medical advice.
Store at a temperature below 30°C, away from moisture and direct sunlight. Keep out of reach of children.
Composition : Ramipril 1.25 mg tablet
Composition : Ramipril 2.5 mg tablet
Composition : Ramipril 5 mg tablet
Composition : Ramipril (10mg) tablet
Composition : Ramipril 2.5 mg + amlodipine 5 mg tablet
Composition : Prasugrel 10 mg Tablets
Composition : Olmesartan Medoxomil (40mg) tablet
Composition : Olmesartan 20 mg + Hydrochlorothiazide 12.50 mg tablet
Composition : Olmesartan 40 mg + hydrochlorothiazide 12.50 mg tablet
Composition : Nitroglycerine 6.4 mg Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ramipril 5 mg + Hydrochlorothiazide 12.5 mg Tablet is a dual-combination antihypertensive medication used for the management of hypertension (high blood pressure). It combines Ramipril, an ACE inhibitor that relaxes blood vessels, with Hydrochlorothiazide, a diuretic that helps remove excess fluid and salt from the body. This synergistic action provides effective and sustained blood pressure control, making it a strong product in the cardiology and cardiovascular care segment, with high demand in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand from cardiologists, physicians, and general practitioners. Combination therapy for hypertension is widely prescribed for better BP control, ensuring regular prescriptions, repeat purchases, and long-term market stability, making it a reliable addition to cardiovascular portfolios.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiac and antihypertensive segment with monopoly rights, quality manufacturing standards, attractive promotional support, and reliable supply chain assistance for distributors and franchise partners.
Wholesalers and distributors benefit from strong prescription volume, long-term patient adherence, increasing prevalence of hypertension, and continuous institutional demand, making this product a profitable and sustainable addition to their pharmaceutical business when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in cardiovascular and antihypertensive formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, promotional support, and PCD pharma franchise opportunities in the cardiac segment.